Zydus On Acquisitions, $100m Specialty Biz Target, Asacol Competition

No Generic Revlimid Sales In Q2

 
• By Vibha Ravi
  
M&As As Part Of Growth Strategy
Acquisitions Are Part Of Zydus' Specialty Growth Strategy • Source: Shutterstock

More from Earnings

More from Business